The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N01 | Anesthetics | |
| 3 | N01B | Anesthetics, local | |
| 4 | N01BB | Amides | |
| 5 | N01BB09 | Ropivacaine |
| Active Ingredient | Description | |
|---|---|---|
| Ropivacaine |
Ropivacaine is a long-acting amide-type local anaesthetic with both anaesthetic and analgesic effects. At high doses ropivacaine produces surgical anaesthesia, while at lower doses it produces sensory block with limited and non-progressive motor block. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| NAROPIN Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| ROPIVACAINE Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
